Synopsys Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Synopsys, Inc. – SNPS
NEW ORLEANS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder…
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 05, 2025 08:00 ET | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine…
Motus Recognized as a 2025 Inc. Power Partner Award Winner
The annual list recognizes the leading B2B companies that have proven track…
Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel
Metabolon to Support Landmark Million Veteran Program 62,000-sample Dataset Advancing Veteran Health…
Zscaler ThreatLabz Reveals 67% Jump in Android Malware and 40% of IoT Attacks Target Critical Industries and Hybrid Work
Key Findings: Critical infrastructure in the energy sector experienced a 387% increase…
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
LANZAJET ANNOUNCES SELECTION OF FLUOR CORPORATION FOR FRONT-END ENGINEERING AND DESIGN (FEED) FOR PROJECT SPEEDBIRD – LANZAJET’S FLAGSHIP UK SAF PLANT
CHICAGO, Nov. 4, 2025 /PRNewswire/ -- LanzaJet, Inc., a leading next-gen fuels…
Oscar Launches New Affordable Health Insurance Choices for San Antonio Individuals, Families, and Businesses
SAN ANTONIO--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…
Fangzhous XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations
SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or…